INCYTE CORPORATION Defined Benefit Plan, Plan Assets, Business Combination
INCYTE CORPORATION (INCY) reported Defined Benefit Plan, Plan Assets, Business Combination of $12.60 million for the 12-month period ending 2016-12-31, per its 10-K filed 2018-02-15.
Discontinued › Notes › Compensation Related Costs › Defined Benefit Plan › Defined Benefit Plan, Roll Forwards
us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets · last filed 2018-02-15
- INCYTE CORPORATION defined benefit plan, plan assets, business combination for fiscal 2016 was $12.60M.
| Period end | Defined Benefit Plan, Plan Assets, Business Combination 12 month |
|---|---|
| 2016-12-31 | $12.60M 10-K · filed 2018-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |